Cargando…

Atrial fibrillation ablation in heart failure with mid-range ejection fraction: Is it time to open the champagne?

Detalles Bibliográficos
Autores principales:	Nagarakanti, Rangadham, Gopinathannair, Rakesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491964/ https://www.ncbi.nlm.nih.gov/pubmed/37652619 http://dx.doi.org/10.1016/j.ipej.2023.08.004

Ejemplares similares

Critical Role of the Posterior Left Atrium in the Perpetuation of Persistent Atrial Fibrillation and the Hybrid Ablation Approach for Persistent Atrial Fibrillation Management: A Single-center Outcomes Study
por: Nagarakanti, Rangadham, et al.
Publicado: (2018)

Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction
por: Son, Mi Kyoung, et al.
Publicado: (2020)

Clinical outcomes and structural remodelling after ablation of atrial fibrillation in heart failure with mildly reduced or mid‐range ejection fraction
por: Lee, Dan‐Ying, et al.
Publicado: (2022)

Atrial Fibrillation can adversely impact Heart Failure with Preserved Ejection Fraction by its association with Heart Failure Progression and Mortality: A Post-Hoc Propensity Score–Matched Analysis of the TOPCAT Americas Trial
por: Saksena, Sanjeev, et al.
Publicado: (2023)

Heart rate in heart failure with mid-range ejection fraction
por: Yılmaz, Mehmet Birhan
Publicado: (2019)

Heart Failure with Mid-Range Ejection Fraction - State of the Art
por: Mesquita, Evandro Tinoco, et al.
Publicado: (2019)

Heart failure with mid-range or mildly reduced ejection fraction
por: Savarese, Gianluigi, et al.
Publicado: (2021)

Advances in the management of atrial fibrillation in congestive heart failure
por: Gopinathannair, Rakesh, et al.
Publicado: (2009)

Treatment of Heart Failure with Mid-Range Ejection Fraction: What Is the Evidence
por: Koufou, Eleni-Evangelia, et al.
Publicado: (2021)

Pulmonary Hypertension in Patients With Heart Failure With Mid-Range Ejection Fraction
por: Maeder, Micha T., et al.
Publicado: (2021)

Left atrial diameter in heart failure with left ventricular preserved, mid-range, and reduced ejection fraction
por: Zhu, Ning, et al.
Publicado: (2019)

Left atrial function and maximal exercise capacity in heart failure with preserved and mid‐range ejection fraction
por: Maffeis, Caterina, et al.
Publicado: (2020)

Atrial fibrillation ablation in patients with heart failure with preserved ejection fraction: Complexities in diagnosis and treatment
por: Ariyaratnam, Jonathan P., et al.
Publicado: (2022)

Outcomes of patients with heart failure with preserved ejection fraction undergoing catheter ablation of atrial fibrillation
por: Krishnamurthy, Amrita, et al.
Publicado: (2022)

Safety, Efficacy and Prognostic Benefit of Atrial Fibrillation Ablation in Heart Failure with Preserved Ejection Fraction
por: Johner, Nicolas, et al.
Publicado: (2022)

Cryoballoon ablation for atrial fibrillation in patients with heart failure with mildly reduced and preserved ejection fraction
por: Chen, Chaofeng, et al.
Publicado: (2022)

Heart failure with preserved ejection fraction and atrial fibrillation: recent advances and open questions
por: Fauchier, Laurent, et al.
Publicado: (2023)

Epicardial fat in heart failure patients with mid‐range and preserved ejection fraction
por: van Woerden, Gijs, et al.
Publicado: (2018)

Heart Failure With Mid-range or Recovered Ejection Fraction: Differential Determinants of Transition
por: Margonato, Davide, et al.
Publicado: (2020)

Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction: A meta‐analysis
por: Gu, Gaoyang, et al.
Publicado: (2022)

Long‐term events following catheter‐ablation for atrial fibrillation in heart failure with preserved ejection fraction
por: Ishiguchi, Hironori, et al.
Publicado: (2022)

Impact of catheter ablation for persistent atrial fibrillation with heart failure, compared to preserved and reduced ejection fraction
por: Inamura, Y, et al.
Publicado: (2023)

The impact of heart rate on patients diagnosed with heart failure with mid-range ejection fraction
por: Xin, Yanguo, et al.
Publicado: (2019)

Atrial Fibrillation in Heart Failure: a Therapeutic Challenge of Our Times
por: Batul, Syeda Atiqa, et al.
Publicado: (2017)

Evaluation of Adherence to Guideline for Heart Failure with Reduced Ejection Fraction in Heart Failure with Preserved Ejection Fraction and with or without Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2021)

Heart failure with mid‐range ejection fraction: characterization of patients from the PINNACLE Registry®
por: Ibrahim, Nasrien E., et al.
Publicado: (2019)

Central and Obstructive Apneas in Heart Failure With Reduced, Mid-Range and Preserved Ejection Fraction
por: Borrelli, Chiara, et al.
Publicado: (2019)

Spironolactone use is associated with improved outcomes in heart failure with mid‐range ejection fraction
por: Enzan, Nobuyuki, et al.
Publicado: (2020)

Rehospitalization burden and morbidity risk in patients with heart failure with mid‐range ejection fraction
por: Santas, Enrique, et al.
Publicado: (2020)

Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides
por: Zhu, Kaiyuan, et al.
Publicado: (2021)

Treatment of Heart Failure With Mid-Range Ejection Fraction: A Summary of Current Evidence
por: Ma, Teng, et al.
Publicado: (2021)

Epicardial Adipose Tissue and Outcome in Heart Failure With Mid-Range and Preserved Ejection Fraction
por: van Woerden, Gijs, et al.
Publicado: (2021)

Breaking the Cycle of Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation
por: Ţica, Otilia, et al.
Publicado: (2022)

Efficacy and safety of spironolactone in the heart failure with mid-range ejection fraction and heart failure with preserved ejection fraction: A meta-analysis of randomized clinical trials
por: Xiang, Yajie, et al.
Publicado: (2019)

Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction: The Misleading Definition of the New Guidelines
por: Fedele, Francesco, et al.
Publicado: (2017)

Silent Cerebral Infarctions with Reduced, Mid-Range and Preserved Ejection Fraction in Patients with Heart Failure
por: Oliveira, Márcia Maria Carneiro, et al.
Publicado: (2018)

The prognosis of mid‐range ejection fraction heart failure: a systematic review and meta‐analysis
por: Altaie, Saif, et al.
Publicado: (2018)

Particularities of Older Patients with Obstructive Sleep Apnea and Heart Failure with Mid-Range Ejection Fraction
por: Ardelean, Carmen Loredana, et al.
Publicado: (2019)

Heart Failure With Mid-range Ejection Fraction: A Distinctive Subtype or a Transitional Stage?
por: Zhou, Qing, et al.
Publicado: (2021)

Impact of diastolic dysfunction on outcome in heart failure patients with mid‐range or reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kjnvkqtkkqngi7b4q2cg05bfel